"After working with Dr. Cavenee for two years, we feel his research is unequivocal in the understanding of tumors and how they react under a variety of conditions," said Franklin C. Salisbury, Jr., president of NFCR. "His discoveries are truly at the forefront of cancer research."
Cavenee's research is directed at defining the genetic lesions in human cancer, determining their physiological significance and using such information for therapeutic approaches. His current directions include the molecular dissection of the basis of malignant progression of astrocytic tumors, the differentiation pathways of astrocytes, the role of DNA methylation in cancers of the prostate, and the role of fusion transcription factors in normal development and pediatric neoplasms.
Since 1991 Cavenee has been Director of the San Diego Branch of the Ludwig Institute for Cancer Research and professor of medicine at the University of California, San Diego School of Medicine, where he is also a member of the Rebecca and John Moores UCSD Cancer Center. He is a past-president of the American Association for Cancer Research, a member of the National Academy of Sciences, a fellow of the American Academy of Microbiology, and a fellow of the International Union Against Cancer. He is on the editorial boards of several journals and has served on the Board of Scientific Counselors of the National Cancer Institute and the National Institute of Environmental Health Sciences. His work on the genetic basis of cancer predisposition and
'"/>
Contact: Silas Deane
sdeane@nfcr.org
800-321-2873
Ludwig Institute for Cancer Research
23-Mar-2004